Form 4: Boston Scientific EVP Wendy Carruthers Executes Stock Options Under 10b5-1 Plan

Wendy Carruthers, EVP of Human Resources at Boston Scientific, executed stock options and sold shares under a pre-established Rule 10b5-1 trading plan.

Summary

• Wendy Carruthers, EVP of Human Resources at Boston Scientific, reported transactions involving Boston Scientific common stock on October 1, 2024.
• The transactions included the exercise of stock options at prices of $17.26 and $24.55, resulting in the acquisition of 3,066 and 1,197 shares, respectively.
• Carruthers also disposed of 6,983 shares of common stock at a price of $83.86.
• These transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.
• Following the reported transactions, Carruthers beneficially owns 34,748 shares of common stock and holds options to purchase 6,132 shares at $17.26 and 15,577 shares at $24.55.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, as it simply reports facts.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives, which is a standard practice in publicly traded companies. The use of a pre-established Rule 10b5-1 trading plan is a common method for insiders to manage their stock holdings while avoiding accusations of trading on non-public information.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan suggests the transactions were planned and not based on inside information.

Key Dates